Novartis to sell molecular imaging business to Siemens Healthineers

Novartis is selling off its molecular imaging business for positron emission tomography (PET) scans to Siemens Healthineers for an undisclosed amount, both companies confirmed to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

A STAT analysis shows how top drug companies are starting to take action on climate

This article is adapted from STAT’s exclusive analysis in the STAT Report: “Climate rankings: How top drug companies measure up in combating climate change.” Drug companies

September 28, 2023

The Safety Sensescaping Project: Using Design to prevent mental injury in healthcare

The Safety Sensescaping project, funded by WorkSafe’s WorkWell Mental Health Improvement Fund, is part of Peninsula Health’s Thriving in Health program, which aims to create

July 19, 2023

Verastem Oncology submits NDA for ovarian cancer treatment

Verastem initiated the rolling NDA submission in May. Credit: Jo Panuwat D via Shutterstock. Verastem Oncology has concluded the rolling submission of a new drug

November 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.